Aligos Therapeutics Inc (ALGS)
0.8013
-0.02
(-2.04%)
USD |
NASDAQ |
Apr 26, 13:53
Aligos Therapeutics Market Cap: 60.63M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 61.90M |
| April 24, 2024 | 62.73M |
| April 23, 2024 | 62.32M |
| April 22, 2024 | 60.61M |
| April 19, 2024 | 56.75M |
| April 18, 2024 | 60.01M |
| April 17, 2024 | 59.55M |
| April 16, 2024 | 63.18M |
| April 15, 2024 | 67.70M |
| April 12, 2024 | 75.67M |
| April 11, 2024 | 80.21M |
| April 10, 2024 | 78.70M |
| April 09, 2024 | 80.21M |
| April 08, 2024 | 80.97M |
| April 05, 2024 | 78.70M |
| April 04, 2024 | 73.59M |
| April 03, 2024 | 76.43M |
| April 02, 2024 | 74.00M |
| April 01, 2024 | 71.99M |
| March 28, 2024 | 74.16M |
| March 27, 2024 | 74.08M |
| March 26, 2024 | 77.18M |
| March 25, 2024 | 71.03M |
| March 22, 2024 | 74.91M |
| March 21, 2024 | 71.89M |
| Date | Value |
|---|---|
| March 20, 2024 | 72.11M |
| March 19, 2024 | 70.49M |
| March 18, 2024 | 69.62M |
| March 15, 2024 | 69.73M |
| March 14, 2024 | 65.81M |
| March 13, 2024 | 65.83M |
| March 12, 2024 | 65.83M |
| March 11, 2024 | 66.59M |
| March 08, 2024 | 63.57M |
| March 07, 2024 | 69.84M |
| March 06, 2024 | 73.60M |
| March 05, 2024 | 75.08M |
| March 04, 2024 | 74.35M |
| March 01, 2024 | 84.86M |
| February 29, 2024 | 74.35M |
| February 28, 2024 | 72.09M |
| February 27, 2024 | 71.34M |
| February 26, 2024 | 68.34M |
| February 23, 2024 | 56.32M |
| February 22, 2024 | 60.08M |
| February 21, 2024 | 50.01M |
| February 20, 2024 | 48.04M |
| February 16, 2024 | 48.81M |
| February 15, 2024 | 48.21M |
| February 14, 2024 | 48.81M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
25.95M
Minimum
Oct 23 2023
1.282B
Maximum
Jun 11 2021
313.70M
Average
66.35M
Median
Jul 18 2022
Market Cap Benchmarks
| Mirum Pharmaceuticals Inc | 1.165B |
| CEL-SCI Corp | 76.38M |
| AIM ImmunoTech Inc | 21.16M |
| IGC Pharma Inc | 28.36M |
| NovaBay Pharmaceuticals Inc | 2.510M |
Market Cap Related Metrics
| PS Ratio | 2.641 |
| Price to Book Value | 0.6585 |
| Price | 0.8013 |
| Earnings Yield | -217.3% |